Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
HRTS
HRTS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest HRTS ETF News Today | Earnings, Events & Price Alerts
HRTS News
EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss
Dec 20 2024
Benzinga
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR
Oct 17 2024
NASDAQ.COM
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win
Oct 16 2024
NASDAQ.COM
EXCLUSIVE: Novo Nordisk Faces Political Heat Over Weight-Loss Drug Prices Ahead Of Elections, Yet 'The Real Issue Is With The Middlemen'
Sep 25 2024
Benzinga
Tap the Weight-Loss Drug Market With These ETFs
Sep 18 2024
NASDAQ.COM
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Jul 18 2024
Benzinga
ETFs to Profit from the Weight Loss Drug Boom
Jun 04 2024
NASDAQ.COM
Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply
May 29 2024
Benzinga
This weight-loss ETF has performed well. Here’s a look at other options.
Apr 10 2024
MarketWatch
Healthcare ETFs for the Weight-Loss Drug Boom & Beyond
Apr 08 2024
NASDAQ.COM
Show More News
